Perry Andrew - Insider Non-Derivative Transactions at G1 Therapeutics, Inc. (GTHX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 18, 2024, Perry Andrew's relationship to G1 Therapeutics, Inc. (GTHX) is Officer (Chief Commercial Officer), and currently has 128,714 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other GTHX insiders.
Data Source: SEC.
Perry Andrew - Insider Non-Derivative Transactions of GTHX Common Stock
Perry Andrew - Insider Non-Derivative Transactions at GTHX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 19, 2024 | U -- (Common Stock) | 14232 | 0 | 0 |
| Sep 19, 2024 | Disposition -- (Common Stock) | 114482 | 0 | 14232 |
| Sep 19, 2024 | Acquisition -- (Common Stock) | 16100 | 0 | 128714 |
| Jul 6, 2024 | Sell -- (Common Stock) | 1337 | 2.51 | 112614 |
| Jul 2, 2024 | Acquisition -- (Common Stock) | 35000 | 0 | 113951 |
| May 14, 2024 | Sell -- (Common Stock) | 8151 | 4.79 | 78951 |
| Jan 4, 2024 | Sell -- (Common Stock) | 2034 | 3.12 | 87102 |
| Jan 4, 2024 | Sell -- (Common Stock) | 379 | 3.12 | 89136 |
| Jan 4, 2024 | Acquisition -- (Common Stock) | 33570 | 0 | 89515 |
| Jul 6, 2023 | Sell -- (Common Stock) | 355 | 2.45 | 55945 |
| May 11, 2023 | Acquisition -- (Common Stock) | 35000 | 0 | 56300 |
| Jan 5, 2023 | Sell -- (Common Stock) | 820 | 5.58 | 21300 |
| Jan 4, 2023 | Acquisition -- (Common Stock) | 16100 | 0 | 22120 |